[[1] Pertwee R.G., Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond, Addict. Biol., 2008, 13, 147-159
10.1111/j.1369-1600.2008.00108.x18482430]Search in Google Scholar
[[2] Auwarter V., Dresen S., Weinmann W., Muller M., Putz M., Ferreiros N., ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?, J. Mass Spectrom., 2009, 44, 832-837
10.1002/jms.155819189348]Search in Google Scholar
[[3] Uchiyama N., Kikura-Hanajiri R., Kawahara N., Haishima Y., Goda Y., Identification of a cannabinoid analog as a new type of designer drug in a herbal product, Chem. Pharm. Bull. (Tokyo), 2009, 57, 439-441
10.1248/cpb.57.43919336947]Search in Google Scholar
[[4] Dresen S., Ferreiros N., Putz M., Westphal F., Zimmermann R., Auwarter V., Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds, J. Mass Spectrom., 2010, 45, 1186-1194
10.1002/jms.181120857386]Search in Google Scholar
[[5] Shanks K.G., Dahn T., Behonick G., Terrell A., Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry, J. Anal. Toxicol., 2012, 36, 360-371
10.1093/jat/bks04722586208]Search in Google Scholar
[[6] Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y., URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products, Forensic Sci. Int., 2013, 227, 21-32
10.1016/j.forsciint.2012.08.04723063179]Search in Google Scholar
[[7] European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2013: Trends and Developments. 2013, http://www.emcdda.europa.eu/publications/edr/trends-developments/2013
]Search in Google Scholar
[[8] Kacinko S.L., Xu A., Homan J.W., McMullin M.M., Warrington D.M., Logan B.K., Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood, J. Anal. Toxicol., 2011, 35, 386-393
10.1093/anatox/35.7.38621871146]Search in Google Scholar
[[9] Shanks K.G., Dahn T., Terrell A.R., Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework, J. Anal. Toxicol., 2012, 36, 145-152
10.1093/jat/bks01322417829]Search in Google Scholar
[[10] Dresen S., Kneisel S., Weinmann W., Zimmermann R., Auwarter V., Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples, J. Mass Spectrom., 2011, 46, 163-171
10.1002/jms.187721259394]Search in Google Scholar
[[11] Strano-Rossi S., Anzillotti L., Castrignano E., Romolo F.S., Chiarotti M., Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, “spice” and stimulants in oral fluid, J. Chromatogr. A, 2012, 1258, 37-42
10.1016/j.chroma.2012.07.09822939380]Search in Google Scholar
[[12] Kneisel S., Auwarter V., Kempf J., Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry, Drug Test. Anal., 2013,5,657-69, DOI: 10.1002/dta 1429
]Search in Google Scholar
[[13] Moran C.L., Le V.H., Chimalakonda K.C., Smedley A.L., Lackey F.D., Owen S.N.et al., Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine, Anal. Chem., 2011, 83, 4228-4236
10.1021/ac2005636310546721506519]Search in Google Scholar
[[14] Hutter M., Broecker S., Kneisel S., Auwarter V., Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS/MS techniques, J. Mass Spectrom., 2012, 47, 54-65
10.1002/jms.202622282090]Search in Google Scholar
[[15] Wohlfarth A., Scheidweiler K.B., Chen X., Liu H.F., Huestis M.A., Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search, Anal. Chem., 2013, 85, 3730-3738
10.1021/ac3037365387440623458260]Search in Google Scholar
[[16] Teske J., Weller J.P., Fieguth A., Rothamel T., Schulz Y., Troger H.D., Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2010, 878, 2659-2663
10.1016/j.jchromb.2010.03.01620378423]Search in Google Scholar
[[17] Chimalakonda K.C., Seely K.A., Bratton S.M., Brents L.K., Moran C.L., Endres G.W.et al., Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands, Drug Metab Dispos., 2012, 40, 2174-2184
10.1124/dmd.112.047530347720122904561]Search in Google Scholar
[[18] Sobolevsky T., Prasolov I., Rodchenkov G., Detection of JWH-018 metabolites in smoking mixture post-administration urine, Forensic Sci. Int., 2010, 200, 141-147
10.1016/j.forsciint.2010.04.00320430547]Search in Google Scholar
[[19] Sobolevsky T., Prasolov I., Rodchenkov G., Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids, Drug Test. Anal., 2012, DOI: 10.1002/dta. 1418
]Search in Google Scholar
[[20] Musshoff F., Madea B., Kernbach-Wighton G., Bicker W., Kneisel S., Hutter M.et al., Driving under the influence of synthetic cannabinoids (“Spice”): a case series, Int. J. Legal Med., 2013, DOI: 10.1007/s00414-013-0864-1
10.1007/s00414-013-0864-123636569]Search in Google Scholar
[[21] Hermanns-Clausen M., Kneisel S., Szabo B., Auwarter V., Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings, Addiction, 2013, 108, 534-544
10.1111/j.1360-0443.2012.04078.x22971158]Search in Google Scholar
[[22] Gunderson E.W., Haughey H.M., Ait-Daoud N., Joshi A.S., Hart C.L., “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans, Am. J. Addict., 2012, 21, 320-326
10.1111/j.1521-0391.2012.00240.x22691010]Search in Google Scholar
[[23] Bekendtgørelse om ændring af bekendtgørelse om klassificering af færdselssikkerhedsfarlige stoffer, bilag 1, https://www.retsinformation.dk/Forms/R0710.aspx?id=138271#B1
]Search in Google Scholar
[[24] Andersen D., Rasmussen B., Linnet K., Validation of a fully automated robotic setup for preparation of whole blood samples for LC-MS toxicology analysis, J. Anal. Toxicol., 2012, 36, 280-287
10.1093/jat/bks01422474214]Search in Google Scholar
[[25] Rivier L., Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis, Analytica Chimica Acta, 2003, 492, 69-82
10.1016/S0003-2670(03)00889-4]Search in Google Scholar
[[26] Ginsburg B.C., McMahon L.R., Sanchez J.J., Javors M.A., Purity of synthetic cannabinoids sold online for recreational use, J. Anal. Toxicol., 2012, 36, 66-68
10.1093/jat/bkr018352396322290755]Search in Google Scholar
[[27] Pedersen A.J., Dalsgaard P.W., Rode A.J., Rasmussen B.S., Muller I.B., Johansen S.S.et al., Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition, J. Sep. Sci., 2013, 36, 2081-2089, DOI: 10.1002/jssc.201200921
10.1002/jssc.20120092123610028]Search in Google Scholar
[[28] Sundhedsstyrelsen, Illegale stoffer i Danmark, Årsrapport 2012. 2013
]Search in Google Scholar
[[29] Lovett D.P., Yanes E.G., Herbelin T.W., Knoerzer T.A., Levisky J.A., Structure elucidation and identification of a common metabolite for naphthoylindole-based synthetic cannabinoids using LC-TOF and comparison to a synthetic reference standard, Forensic Sci. Int., 2013, 226, 81-8710.1016/j.forsciint.2012.12.01223313601]Search in Google Scholar